Lincoln Pharmaceuticals Ltd (LINCOLN) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 294056, "name": "Lincoln Pharma.", "stock_name": "Lincoln Pharma.", "full_name": "Lincoln Pharmaceuticals Ltd", "name_url": "stocks-analysis/lincoln-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "733.40", "chg": 2.35, "chgp": "0.32%", "dir": 1, "prev_price": "731.05", "mcapval": "1,492.00 Cr", "mcap": "Micro Cap", "scripcode": 531633, "symbol": "LINCOLN", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE405C01035", "curr_date": "May 22", "curr_time": "", "bse_nse_vol": "1.47 lacs", "exc_status": "Active", "traded_date": "May 22, 2026", "traded_date_str": "2026 05 22", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lincoln-pharma-294056-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Lincoln Pharmaceuticals Gains 13.70%: 3 Key Factors Driving the Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-gains-1370-3-key-factors-driving-the-rally-4009398", "imagepath": "", "date": "2026-05-24 11:00:49", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>May 18:</strong> Technical momentum shifts signal bullish outlook</p>\n <p><strong>May 21:</strong> New 52-week high reached at Rs.732.45</p>\n <p><strong>May 22:</strong> Further 52-week high at Rs.745.1</p>\n <p><strong>Week Close:</strong> Rs.733.40 (+13.70%) vs Sensex +0.50%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.645.05</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.733.40</div><div class=\"stat-change positive\">+13..." }, { "title": "Lincoln Pharmaceuticals Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/lincoln-pharmaceuticals-ltd-is-rated-hold-4005014", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/LincolnPharmace_mojoScore_4005014.png", "date": "2026-05-22 10:10:03", "description": "Lincoln Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "Broad-Based Technical Strength Lifts Lincoln Pharmaceuticals Ltd to 52-Week High of Rs 745.1", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-hits-new-52-week-high-at-rs7451-4004632", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/LincolnPharmace_priceRelatedfactors_4004632.png", "date": "2026-05-22 09:41:56", "description": "With a decisive breakthrough to Rs 745.1 on 22 May 2026, Lincoln Pharmaceuticals Ltd has reached a fresh 52-week high, extending its impressive 34.8% gain over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained outperformance relative to the broader market indices." }, { "title": "Broad-Based Technical Strength Lifts Lincoln Pharmaceuticals Ltd to 52-Week High of Rs 732.45", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-hits-new-52-week-high-at-rs73245-4003156", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/LincolnPharmace_priceRelatedfactors_4003156.png", "date": "2026-05-21 13:40:14", "description": "With a decisive surge to Rs 732.45 on 21 May 2026, Lincoln Pharmaceuticals Ltd has reached a fresh 52-week high, marking a 66.4% rally from its low of Rs 439.95 over the past year. This milestone comes amid a backdrop of strong technical momentum, even as the broader market shows signs of volatility." }, { "title": "When is the next results date for Lincoln Pharmaceuticals Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-lincoln-pharmaceuticals-ltd-3999640", "imagepath": "", "date": "2026-05-19 23:17:14", "description": "The next results date for Lincoln Pharmaceuticals Ltd is scheduled for 28 May 2026...." }, { "title": "Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-technical-momentum-shifts-signal-bullish-outlook-3995861", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/LincolnPharmace_technicaldot_3995861.png", "date": "2026-05-18 08:00:35", "description": "Lincoln Pharmaceuticals Ltd has witnessed a notable shift in its technical momentum, upgrading from a mildly bullish to a bullish stance as of mid-May 2026. Despite a recent day decline of 2.83%, the stock’s technical indicators reveal a complex interplay of bullish and neutral signals, suggesting cautious optimism for investors amid mixed market conditions." }, { "title": "Lincoln Pharmaceuticals Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/lincoln-pharmaceuticals-ltd-is-rated-hold-3985477", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/LincolnPharmace_mojoScore_3985477.png", "date": "2026-05-11 10:10:02", "description": "Lincoln Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 Mar 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 11 May 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing." }, { "title": "Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3974666", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/LincolnPharmace_technicaldot_3974666.png", "date": "2026-05-05 08:01:25", "description": "Lincoln Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish trend as of early May 2026. Despite a slight dip in daily price, key technical indicators present a mixed picture, signalling both opportunities and caution for investors navigating the pharmaceuticals and biotechnology sector." }, { "title": "Lincoln Pharmaceuticals Gains 6.93%: 2 Key Factors Driving the Week’s Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-gains-693-2-key-factors-driving-the-weeks-momentum-3971891", "imagepath": "", "date": "2026-05-03 11:00:04", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Apr 27:</strong> Valuation upgrade signals renewed price attractiveness</p>\n <p><strong>Apr 29:</strong> New 52-week high reached at Rs.710.9</p>\n <p><strong>Apr 30:</strong> Profit-taking leads to a 4.19% correction</p>\n <p><strong>May 1:</strong> No trading data available</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.603.55</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.645.40</div><div class=\"stat-change positive\">+6.93..." } ], "total": 979, "sid": "294056", "stock_news_url": "https://www.marketsmojo.com/news/lincoln-pharmaceuticals-294056" }, "announcements": [ { "caption": "Board Meeting Intimation for Consideration Of Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter And Year Ended On March 31 2026.", "datetime": "18-May-2026", "details": "Lincoln Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 inter alia to consider and approve Audited (standalone and consolidated) financial results of the Company for the quarter and year ended on March 31 2026.", "source": "BSE" }, { "caption": "Corporate Action-Board to consider Dividend", "datetime": "18-May-2026", "details": "Meeting of the Board of Directors is scheduled to be held on May 28 2026 to consider and approve Audited Financial Results of the Company and recommendation of Dividend on equity shares of the Company if any.", "source": "BSE" }, { "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance", "datetime": "12-May-2026", "details": "Annual Secretarial Compliance Report for the financial year ended March 31 2026.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "", "data": [ { "title": "BOARD MEETING", "txt": "28 May 2026" } ] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Lincoln Pharmaceuticals Ltd has declared <strong>18%</strong> dividend, ex-date: 12 Sep 25", "dt": "2025-09-12", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Lincoln Pharmaceuticals Ltd has announced <strong>10:2</strong> stock split, ex-date: 19 Mar 09", "dt": "2009-03-19", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

May 18: Technical momentum shifts signal bullish outlook

May 21: New 52-week high reached at Rs.732.45

May 22: Further 52-week high at Rs.745.1

Week Close: Rs.733.40 (+13.70%) vs Sensex +0.50%

Read full news article

Lincoln Pharmaceuticals Ltd is Rated Hold

2026-05-22 10:10:03

Lincoln Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Broad-Based Technical Strength Lifts Lincoln Pharmaceuticals Ltd to 52-Week High of Rs 745.1

2026-05-22 09:41:56

With a decisive breakthrough to Rs 745.1 on 22 May 2026, Lincoln Pharmaceuticals Ltd has reached a fresh 52-week high, extending its impressive 34.8% gain over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained outperformance relative to the broader market indices.

Read full news article

Broad-Based Technical Strength Lifts Lincoln Pharmaceuticals Ltd to 52-Week High of Rs 732.45

2026-05-21 13:40:14

With a decisive surge to Rs 732.45 on 21 May 2026, Lincoln Pharmaceuticals Ltd has reached a fresh 52-week high, marking a 66.4% rally from its low of Rs 439.95 over the past year. This milestone comes amid a backdrop of strong technical momentum, even as the broader market shows signs of volatility.

Read full news article

When is the next results date for Lincoln Pharmaceuticals Ltd?

2026-05-19 23:17:14

The next results date for Lincoln Pharmaceuticals Ltd is scheduled for 28 May 2026....

Read full news article

Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-05-18 08:00:35

Lincoln Pharmaceuticals Ltd has witnessed a notable shift in its technical momentum, upgrading from a mildly bullish to a bullish stance as of mid-May 2026. Despite a recent day decline of 2.83%, the stock’s technical indicators reveal a complex interplay of bullish and neutral signals, suggesting cautious optimism for investors amid mixed market conditions.

Read full news article

Lincoln Pharmaceuticals Ltd is Rated Hold

2026-05-11 10:10:02

Lincoln Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 Mar 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 11 May 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing.

Read full news article

Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-05-05 08:01:25

Lincoln Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish trend as of early May 2026. Despite a slight dip in daily price, key technical indicators present a mixed picture, signalling both opportunities and caution for investors navigating the pharmaceuticals and biotechnology sector.